---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-023035"
form_type: "8-K"
ticker: "RMTI"
cik: "0001041024"
company_name: "ROCKWELL MEDICAL, INC."
filed_at: "2024-05-14T23:59:59+00:00"
generated_at: "2026-06-02T00:10:59.360442+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Rockwell Medical Q1 record sales $22.7M (+15% YoY); raises 2024 guidance across all metrics

## Summary
- Q1 net sales $22.7M (record), up 15% YoY; ex-deferred revenue, up 25%. Gross profit $3.1M (+18% YoY).
- Net loss improved to $1.7M from $1.8M YoY; adjusted EBITDA ($0.5M) vs ($1.0M).
- Raised FY2024 guidance: net sales $90-94M (prev $84-88M); gross profit $13-15M; adjusted EBITDA $0.5-1.0M.
- Amended Innovatus loan: rate reduced, maturity extended to Jan 2029; interest-only through Sep 2026.
- New distribution deals with BioNuclear and AMI expected ~$1M annual revenue; new supply agreement with large Mountain West health system.

## SEC filing metadata
- accession: 0001628280-24-023035
- form_type: 8-K
- ticker: RMTI
- cik: 0001041024
- company_name: ROCKWELL MEDICAL, INC.
- filed_at: 2024-05-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1041024/000162828024023035/0001628280-24-023035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1041024/000162828024023035/rmti-20240514.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-023035
- JSON: https://secwatch.observer/filing/0001628280-24-023035.json
- Plain text: https://secwatch.observer/filing/0001628280-24-023035.txt

## Key facts
- Earnings Releases
  ROCKWELL MEDICAL, INC. reported three months ended March 31, 2024 results: revenue $22.7 million, net income Net loss of $1.7 million, EPS $(0.06). Guidance raised.
  - Period: three months ended March 31, 2024
  - Revenue: $22.7 million
  - Net income: Net loss of $1.7 million
  - EPS: $(0.06)
  - Guidance: raised
  - Result: reported results
  source text: by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- Rockwell Medical Announces First Quarter 2024 Results, Raises 2024 Guidance • Reports record net sales of $22.7 million for the first quarter of 2024, an increase of 25% over net product sales and a 15% increase over net sales for the same period in 2023. • Reports record gross profit of $3.1
  evidence_url: https://www.sec.gov/Archives/edgar/data/1041024/000162828024023035/0001628280-24-023035-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.